docetaxel anhydrous and betadex
docetaxel anhydrous has been researched along with betadex in 20 studies
Compound Research Comparison
Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (betadex) | Trials (betadex) | Recent Studies (post-2010) (betadex) |
---|---|---|---|---|---|
12,110 | 3,216 | 6,920 | 8,785 | 97 | 4,452 |
Research
Studies (20)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (5.00) | 18.2507 |
2000's | 1 (5.00) | 29.6817 |
2010's | 17 (85.00) | 24.3611 |
2020's | 1 (5.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Bressolle, F; Grosse, PY; Pinguet, F | 1 |
Baussanne, I; Benito, JM; Defaye, J; García Fernández, JM; Gómez-García, M; Ortiz Mellet, C | 1 |
Chen, C; Huang, XX; Ren, Y; Wang, H; Xu, Q; Yu, SQ; Zhou, CL; Zhu, YY | 1 |
Bouchemal, K; Cheron, M; Gallard, JF; Gueutin, C; Iorga, BI; Mazzaferro, S; Ponchel, G; Steinmesse, C | 1 |
Kim, EJ; Kim, TK; Lee, BY; Park, JH; Yoo, HH | 1 |
Fang, L; Shen, Q; Wu, J | 1 |
Kim, IS; Kim, TK; Yoo, HH | 1 |
Bouchemal, K; Chacun, H; Gueutin, C; Mazzaferro, S; Ponchel, G; Skanji, R | 1 |
Kim, EJ; Kim, TK; Lee, BY; Park, JH; Sa, JH; Yoo, HH | 1 |
Arra, C; Barbieri, A; Bimonte, S; Conte, C; Luciano, A; Palma, G; Quaglia, F; Rea, D; Tirino, P; Ungaro, F | 1 |
Fan, Y; Huang, X; Liang, Z; Pan, J; Yi, C; Zhang, Y; Zhao, L | 1 |
Bansal, S; Ferrati, S; Grattoni, A; Hosali, S; Landis, M; Nicolov, E | 1 |
Chen, K; Gong, H; Guo, J; Han, S; Li, X; Wei, Y; Zhang, D; Zhang, J | 1 |
Bu, X; Dou, L; Fang, L; Shen, Q; Wu, J | 1 |
Jiang, G; Liu, F; Liu, T; Wang, W; Wang, Y; Wu, T; Wu, X; Xie, M; Zhang, T | 1 |
Belaaloui, G; Jiang, ZZ; Khaled, M; Zhang, LY; Zhu, X | 1 |
Hu, Q; Kirk, TB; Ma, D; Tang, Q; Wu, J; Xu, J; Xu, Z; Xue, W; Zhang, Y | 1 |
Hou, X; Jiang, G; Liu, T; Wang, Y; Wu, T; Wu, X; Xie, H; Xie, M | 1 |
Feng, Z; He, L; Huang, J; Li, B; Li, W; Liu, J; Ma, Y; Wang, K; Wang, Q; Yang, X; Zheng, Y | 1 |
Chaudhari, D; Desai, MR; Jain, S; Katiyar, SS; Kuche, K; Nallamothu, B | 1 |
Other Studies
20 other study(ies) available for docetaxel anhydrous and betadex
Article | Year |
---|---|
In vitro modulation of doxorubicin and docetaxel antitumoral activity by methyl-beta-cyclodextrin.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; beta-Cyclodextrins; Breast Neoplasms; Cisplatin; Cyclodextrins; Docetaxel; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Female; Fluorouracil; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Ovarian Neoplasms; Paclitaxel; Taxoids; Tumor Cells, Cultured | 1998 |
Optimizing saccharide-directed molecular delivery to biological receptors: design, synthesis, and biological evaluation of glycodendrimer-cyclodextrin conjugates.
Topics: beta-Cyclodextrins; Concanavalin A; Cyclodextrins; Docetaxel; Drug Carriers; Humans; Lectins; Lectins, C-Type; Macrophages; Mannose Receptor; Mannose-Binding Lectins; Models, Molecular; Nuclear Magnetic Resonance, Biomolecular; Oligosaccharides; Paclitaxel; Receptors, Cell Surface; Taxoids | 2004 |
Pharmacokinetics, efficacy, and safety evaluation of docetaxel/hydroxypropyl-sulfobutyl-β-cyclodextrin inclusion complex.
Topics: Animals; beta-Cyclodextrins; Docetaxel; Drug Delivery Systems; HCT116 Cells; Hep G2 Cells; Humans; Male; Mice; Neoplasms; Rabbits; Random Allocation; Rats; Rats, Wistar; Taxoids; Treatment Outcome; Xenograft Model Antitumor Assays | 2011 |
Bivalent sequential binding of docetaxel to methyl-β-cyclodextrin.
Topics: beta-Cyclodextrins; Chemistry, Pharmaceutical; Circular Dichroism; Cyclodextrins; Docetaxel; Entropy; Models, Molecular; Molecular Structure; Solubility; Taxoids | 2011 |
Pharmacokinetic equivalence of Taxotere and SID530, a novel docetaxel formulation containing hydroxypropyl-beta-cyclodextrin in monkeys.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; Antineoplastic Agents, Phytogenic; Area Under Curve; beta-Cyclodextrins; Calibration; Chemistry, Pharmaceutical; Docetaxel; Excipients; Macaca fascicularis; Male; Reference Standards; Tandem Mass Spectrometry; Taxoids; Therapeutic Equivalency | 2012 |
Sulfobutylether-β-cyclodextrin/chitosan nanoparticles enhance the oral permeability and bioavailability of docetaxel.
Topics: Administration, Oral; Animals; Antineoplastic Agents; beta-Cyclodextrins; Biological Availability; Chitosan; Docetaxel; Drug Delivery Systems; Male; Nanoparticles; Permeability; Rats; Rats, Wistar; Spectroscopy, Fourier Transform Infrared; Taxoids; X-Ray Diffraction | 2013 |
Determination of docetaxel in rat plasma and its application in the comparative pharmacokinetics of Taxotere and SID530, a novel docetaxel formulation with hydroxypropyl-β-cyclodextrin.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; Area Under Curve; beta-Cyclodextrins; Chromatography, Liquid; Docetaxel; Male; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry; Taxoids | 2013 |
Intestinal permeation enhancement of docetaxel encapsulated into methyl-β-cyclodextrin/poly(isobutylcyanoacrylate) nanoparticles coated with thiolated chitosan.
Topics: Animals; Antineoplastic Agents; beta-Cyclodextrins; Chitosan; Cyanoacrylates; Docetaxel; Enbucrilate; In Vitro Techniques; Intestinal Absorption; Jejunum; Male; Nanoparticles; Pancreatin; Permeability; Rats; Rats, Wistar; Taxoids | 2012 |
Comparative protein binding of taxotere and SID530, a new docetaxel formulation with hydroxypropyl-beta-cyclodextrin, in human plasma in vitro.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Antineoplastic Agents, Phytogenic; beta-Cyclodextrins; Blood Proteins; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Dialysis; Docetaxel; Humans; Indicators and Reagents; Mass Spectrometry; Powders; Protein Binding; Reproducibility of Results; Taxoids; Therapeutic Equivalency | 2012 |
Antitumor activity of PEGylated biodegradable nanoparticles for sustained release of docetaxel in triple-negative breast cancer.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; Antineoplastic Agents; beta-Cyclodextrins; Blood Proteins; Cell Line, Tumor; Cell Survival; Delayed-Action Preparations; Docetaxel; Ethylene Glycols; Female; Humans; Mammary Neoplasms, Experimental; Mice, Nude; Nanoparticles; Polyesters; Powders; Taxoids; Triple Negative Breast Neoplasms; Tumor Burden | 2014 |
Magnetic Fe₃ O ₄ nanoparticles grafted with single-chain antibody (scFv) and docetaxel loaded β-cyclodextrin potential for ovarian cancer dual-targeting therapy.
Topics: Antigens, CD; Antineoplastic Agents; beta-Cyclodextrins; Cell Line, Tumor; Cell Survival; Delayed-Action Preparations; Docetaxel; Drug Carriers; Endoglin; Female; Human Umbilical Vein Endothelial Cells; Humans; Magnetite Nanoparticles; Ovarian Neoplasms; Receptors, Cell Surface; Single-Chain Antibodies; Taxoids | 2014 |
Docetaxel/2-Hydroxypropyl β -Cyclodextrin Inclusion Complex Increases Docetaxel Solubility and Release from a Nanochannel Drug Delivery System.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; Antineoplastic Agents; beta-Cyclodextrins; Delayed-Action Preparations; Docetaxel; Drug Delivery Systems; Female; Humans; Mice; Mice, SCID; Taxoids; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays | 2015 |
Engineering of Biocompatible pH-Responsive Nanovehicles from Acetalated Cyclodextrins as Effective Delivery Systems for Tumor Therapy.
Topics: Animals; Antineoplastic Agents; beta-Cyclodextrins; Biocompatible Materials; Cells, Cultured; Docetaxel; Drug Carriers; Drug Delivery Systems; Hep G2 Cells; Humans; Hydrogen-Ion Concentration; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Neoplasms; Polymers; Taxoids | 2015 |
Co-Delivery of Docetaxel and Berbamine by Chitosan/Sulfobutylether-β-Cyclodextrin Nanoparticles for Enhancing Bioavailability and Anticancer Activities.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Benzylisoquinolines; beta-Cyclodextrins; Biological Availability; Cell Survival; Chitosan; Diffusion; Docetaxel; Dose-Response Relationship, Drug; Drug Synergism; Male; MCF-7 Cells; Mice; Nanocapsules; Neoplasms, Experimental; Rats; Rats, Wistar; Taxoids | 2015 |
Folate-targeted star-shaped cationic copolymer co-delivering docetaxel and MMP-9 siRNA for nasopharyngeal carcinoma therapy.
Topics: Animals; Apoptosis; beta-Cyclodextrins; Carcinoma; Cell Line, Tumor; Docetaxel; Drug Delivery Systems; Female; Folic Acid; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genetic Therapy; Humans; Hydrophobic and Hydrophilic Interactions; Magnetic Resonance Spectroscopy; Matrix Metalloproteinase 9; Mice; Mice, Inbred BALB C; Mice, Nude; Micelles; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Polylysine; Proliferating Cell Nuclear Antigen; RNA, Small Interfering; Taxoids; Tissue Distribution; Transfection | 2016 |
Antitumor effect of Deoxypodophyllotoxin on human breast cancer xenograft transplanted in BALB/c nude mice model.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Administration, Intravenous; Animals; Antineoplastic Agents, Phytogenic; beta-Cyclodextrins; Breast Neoplasms; Cell Line, Tumor; Docetaxel; Drugs, Chinese Herbal; Etoposide; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Podophyllotoxin; Taxoids; Xenograft Model Antitumor Assays | 2016 |
Biocompatible hyperbranched polyglycerol modified β-cyclodextrin derivatives for docetaxel delivery.
Topics: Adenocarcinoma; beta-Cyclodextrins; Breast Neoplasms; Cell Line; Delayed-Action Preparations; Docetaxel; Drug Screening Assays, Antitumor; Erythrocytes; Female; Glycerol; Hemolysis; Humans; Polymers; Taxoids | 2017 |
CD-PLLD co-delivering docetaxel and MMP-9 siRNA plasmid for nasopharyngeal carcinoma therapy in vivo.
Topics: Animals; beta-Cyclodextrins; Carcinoma; Cell Line, Tumor; Docetaxel; Drug Carriers; Humans; Matrix Metalloproteinase 9; Mice; Mice, Inbred BALB C; Mice, Nude; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Polylysine; Proliferating Cell Nuclear Antigen; RNA, Small Interfering; Taxoids; Transplantation, Heterologous | 2017 |
Self-Assembled Supramolecular Nanoparticles for Targeted Delivery and Combination Chemotherapy.
Topics: Antineoplastic Agents; Aptamers, Nucleotide; Base Sequence; beta-Cyclodextrins; Cell Line, Tumor; DNA; Docetaxel; Doxorubicin; Drug Carriers; Drug Combinations; Drug Synergism; Humans; Nanoparticles; Propylene Glycols; Theranostic Nanomedicine | 2018 |
Partial inclusion complex assisted crosslinked β-cyclodextrin nanoparticles for improving therapeutic potential of docetaxel against breast cancer.
Topics: Antineoplastic Agents; beta-Cyclodextrins; Breast Neoplasms; Cell Line, Tumor; Docetaxel; Drug Carriers; Female; Humans; Nanoparticles | 2022 |